Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and early intervention for mental health conditions in children and youth.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. Now in its second five-year funding cycle, the MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues are conducting several large studies across MHRN health systems, including:
Dr. Simon is an editor for the Cochrane Collaboration’s depression and anxiety review group, sits on the editorial board for General Hospital Psychiatry, and serves on the advisory board for the National Institutes of Health’s All of Us Program (formerly Precision Medicine Initiative). Earlier, he served on the editorial boards of Psychiatric Services and Psychological Medicine and chaired the scientific advisory board for the Depression and Bipolar Support Alliance. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990 and is a research professor in psychiatry and behavioral sciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Simon G, Wagner E, Vonkorff M. Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol. 1995;48(3):363-73. PubMed
Simon GE, VonKorff M. Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev. 1995;17(1):221-7. PubMed
Simon GE, Von Korff M. Results from the Seattle Center. In: Ustun TB and Sartorius N TB (Eds) Mental Illness in General Health Care; An International Study. John Wiley and Sons, 1995, pp. 265-284.
Wagner EH, VonKorff M, Simon GE. Anxious and depressed patients in primary care: the need for more clinical epidemiology. (Editorial). J Gen Intern Med. 1994;9(9):534-5. PubMed
Sparks PJ, Daniell W, Black DW, Kipen HM, Altman LC, Simon GE, Terr AI. Multiple chemical sensitivity syndrome: a clinical perspective. II. Evaluation, diagnostic testing, treatment, and social considerations. J Occup Med. 1994;36(7):731-7. PubMed
Sparks PJ, Daniell W, Black DW, Kipen HM, Altman LC, Simon GE, Terr AI. Multiple chemical sensitivity syndrome: a clinical perspective. I. Case definition, theories of pathogenesis, and research needs. J Occup Med. 1994;36(7):718-30. PubMed
Simon GE. Psychiatric symptoms in multiple chemical sensitivity. Toxicol Ind Health. 1994;10(4-5):487-96. PubMed
Simon GE, VonKorff M, Durham ML. Predictors of outpatient mental health use in an HMO primary care sample. Am J Psychiatry. 1994;151(6):908-13. PubMed
Katon W, Lin E, von Korff M, Bush T, Walker E, Simon G, Robinson P. The predictors of persistence of depression in primary care. J Affect Disord. 1994;31(2):81-90. PubMed
Revicki DA, Irwin D, Reblando J, Simon GE. The accuracy of self-reported disability days. Med Care. 1994;32(4):401-4. PubMed
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.
KPWHRI researchers are contributing to better mental health care for people nationwide.